ClinicalMetric / Countries / Italy / lymphoma
← 🇮🇹 Italy Trials
🇮🇹 Italy Country × Condition

lymphoma Clinical Trials in Italy

Active clinical trials for lymphoma with research sites in Italy. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 4 // Recruiting: 4 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇮🇹 Italy

Active Trials in Italy (4)

NCT06585124
Recruiting

Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas

Enrollment
150 pts
Country
🇮🇹 Italy
Fondazione Policlinico Universitari...
View Trial →
NCT06895291
Recruiting

Whole Body MRI in Oncology

Enrollment
1,000 pts
Country
🇮🇹 Italy
Istituto Romagnolo per lo Studio de...
View Trial →
NCT06814925
Recruiting

Italian Study of Patients With Lymphoma

Enrollment
1,500 pts
Country
🇮🇹 Italy
IRCCS Azienda Ospedaliero-Universit...
View Trial →
NCT06774326
Recruiting

Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines

Enrollment
160 pts
Country
🇮🇹 Italy
IRCCS Azienda Ospedaliero-Universit...
View Trial →

Frequently Asked Questions

How many lymphoma clinical trials are active in Italy?
There are currently 4 active clinical trials for lymphoma with sites in Italy, of which 4 are actively recruiting patients.
How can I join a lymphoma clinical trial in Italy?
To join a lymphoma clinical trial in Italy, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Italy directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are lymphoma trials in Italy?
Active lymphoma trials in Italy span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Italy Trials → Global lymphoma Trials → All Countries → All Trials →